Kate Haviland, Chief Operating Officer at Blueprint Medicines Corp (BPMC), sold 409 shares at $100.27 ($41K) on 2020-11-16, disclosed to the SEC on 2020-11-18.
Scheduled sale ($41k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |